Torley, Roleda Beltz Roleda Beltz Torley, born July 30, 1920, graduate of Erie High School, died October 21, 2009. She was the wife of the late James Torley. She is survived by her children, Mary Ann ...

Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...

PHILADELPHIA—It has been a big year for Halozyme Therapeutics, and 2019’s not over yet. The biotech inked its ninth licensing deal for its drug delivery platform with its first biotech partner, saw ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

Halozyme Therapeutics (NASDAQ:HALO) executives highlighted the company’s royalty-driven growth outlook and expanding ...

Halozyme CEO Helen Torley has always been frank about what would happen if the company’s foray into drug development failed: The two-pillar company would ditch its internal pipeline and focus solely ...

Helen Torley, the President and CEO of Halozyme Therapeutics NASDAQ:HALO, sold a total of 60,500 shares of common stock between November 10 and November 12, 2025. The sales, executed under a ...

Torley was diagnosed with cancer a few weeks ago and was about to undergo weeks of radiation and chemotherapy treatment. His son said Torley never wanted to be treated as an invalid. Torley at the ...

The deal is expected to close in the third quarter Evercore was financial advisor to Arcosa on the divestiture Stellex has over $2.8 billion in assets under management Stellex Capital Management has ...